Developer docs
API playgroundTry for free, no card

Search company profiles

Grupo WP: Widal Pacheco - Endocrimeta - Conte

Full company profile

uuid004j9sr

Namestring
Grupo WP: Widal Pacheco - Endocrimeta - Conte
Legal namestring
Grupo WP
Websiteurl
grupowp.med.br
Company typeenum
Private
Founded yearint
2009
Descriptiontext

Grupo WP is a privately held Brazilian clinical laboratory group headquartered in Passo Fundo, Rio Grande do Sul, operating a multi-brand diagnostic testing network across 22+ cities in the southern states of Rio Grande do Sul and Santa Catarina. The group was founded in 2007 around the HORUS laboratory and has grown through a series of acquisitions of established regional laboratories now marketed under the Widal Pacheco, Endocrimeta, and Conte brands, with subsequent geographic extension into the Porto Alegre metropolitan region via the 2023 acquisitions of Endocrimeta and Conte. The company remains controlled by the Dalbosco family, with Rafael Dalbosco having assumed operational leadership in 2016 and the group opening its capital structure to external shareholders in 2018 to finance continued acquisitions.

The group's core offering is routine and specialized clinical laboratory diagnostics — primarily blood and endocrinology testing — delivered through a distributed collection-point network serving individual patients, referring physicians, and health-plan operators across southern Brazil. The portfolio is differentiated by Endocrimeta's specialized endocrinology testing focus, complementing the routine diagnostics performed under the Widal Pacheco and Conte brands. Quality is anchored by DICQ certification across the network, the Brazilian diagnostic-industry quality standard that supports contracting with health plans and referral sources.

The business model is a regional roll-up of clinical laboratories: revenue is generated per test under fee-for-service pricing paid by patients, private health plans, and referring physicians, with group-level consolidation of procurement, quality, and back-office functions creating scale economics over the acquired standalone laboratories. Grupo WP has stated an ambition to be among Brazil's leading clinical laboratory groups by 2027, supported by its continued acquisition cadence since 2013. The group reports 86 employees across its network and maintains a dedicated careers portal to support integration of recent acquisitions.

Short descriptiontext

Grupo WP is a Brazilian clinical laboratory group operating across 22+ cities in Rio Grande do Sul and Santa Catarina through acquired regional brands (Widal Pacheco, Endocrimeta, Conte), providing routine and specialized endocrinology diagnostic testing to patients and health plans.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersPasso Fundo, Brazil
HQ citystring
Passo Fundo
HQ countrystring
Brazil
HQ regionstring
Latin America
Markets served

Serves global market

Offices22 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical laboratory services, diagnostic testing services, endocrinology laboratory testing, blood analysis services, medical diagnostic examinations
Industry1 code
1Central Laboratory Services (Core Lab Operations)
CodeHLAGAEAAPrimaryYes
NAICS code1 code
  • Medical Laboratories621511
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Clinical Laboratory Services
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Laboratory Testing Services
TypeOne Time License
Description

Laboratory diagnostic services including clinical analysis, blood tests, specialized examinations, and endocrinology testing (Endocrimeta). Revenue generated through patient examinations and tests, likely on a per-test or service basis.

grupowp.med.br
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Grupo WP operates a multi-brand network of clinical diagnostic laboratories across southern Brazil, delivering routine and specialized medical examinations to individual patients and referring physicians. Its core services include blood tests, clinical analysis, and specialized endocrinology and metabolic testing through the Endocrimeta brand. The group runs more than 22 physical collection and laboratory units in Rio Grande do Sul and Santa Catarina under the Widal Pacheco, Endocrimeta, and Conte brands.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Grupo WP is a unified platform consisting of multiple clinical laboratory brands operating across southern Brazil. The portfolio is structured as a platform-plus-sub-brands architecture, comprising Widal Pacheco (the flagship brand formed from the 2017 fusion of Laboratorio Widal and Laboratorio Pacheco), Endocrimeta, and Conte (both acquired in 2023 to expand into Porto Alegre), along with historical acquisitions including HORUS, Jorgens, and Ambrosio laboratories. The group provides clinical laboratory examination services through 23+ locations across Rio Grande do Sul and Santa Catarina states.

Product and service3 records
1Widal Pacheco
CategoryClinical Laboratory Testing
Description

Clinical laboratory brand formed from the 2017 merger of Laboratorio Widal (Passo Fundo) and Laboratorio Pacheco (Lages), serving Passo Fundo, Lages, and Serra Catarinense regions with general clinical diagnostic testing services.

2Endocrimeta
CategorySpecialized Endocrinology Testing
Description

Clinical laboratory brand acquired in 2023, serving Porto Alegre and metropolitan region with specialization in endocrinology and metabolic testing.

3Conte
CategoryClinical Laboratory Testing
Description

Clinical laboratory brand acquired in 2023 as part of Grupo WP's expansion into Porto Alegre and the metropolitan region.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeOthers
Description

DICQ (Programa de Certificação da Qualidade) is a quality certification program for clinical laboratories. The company displays the DICQ certification logo on their website, indicating compliance with quality standards in laboratory operations.

Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers6 records
TypeRegional player
Description

Established Brazilian clinical laboratory with long-standing regional presence. Comparable in clinical diagnostic service offerings and patient-referral model, though concentrated in different Brazilian regions.

TypeDirect peer
Description

Brazilian clinical diagnostics network with multiple units and a similar patient-and-physician go-to-market. Comparable as a regionally concentrated Brazilian lab competitor pursuing consolidation.

TypeBroad incumbent
Description

Major Brazilian medical diagnostics group with broad clinical lab and imaging services. Comparable as a multi-region, multi-brand clinical lab operator targeting similar patient and physician customers.

TypeDirect peer
Description

Brazilian clinical analysis laboratory group with strong regional footprint and specialty testing capabilities. Comparable as a mid-sized clinical lab group serving patients and physicians across multiple Brazilian states.

TypeBroad incumbent
Description

Largest clinical diagnostics company in Brazil operating a multi-brand national network of labs and hospitals. Directly comparable as a roll-up acquirer in the same clinical lab market, though materially larger and nationally diversified.

TypeDirect peer
Description

Brazilian clinical laboratory and diagnostics group with multi-state presence and a similar multi-brand consolidation strategy. Closely comparable in business model and customer base, though operating at larger national scale.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries7 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Grupo WP: Widal Pacheco - Endocrimeta - Conte

Clinical Laboratory Servicesgrupowp.med.br

Grupo WP is a Brazilian clinical laboratory group operating across 22+ cities in Rio Grande do Sul and Santa Catarina through acquired regional brands (Widal Pacheco, Endocrimeta, Conte), providing routine and specialized endocrinology diagnostic testing to patients and health plans.

What Grupo WP: Widal Pacheco - Endocrimeta - Conte does

Grupo WP is a privately held Brazilian clinical laboratory group headquartered in Passo Fundo, Rio Grande do Sul, operating a multi-brand diagnostic testing network across 22+ cities in the southern states of Rio Grande do Sul and Santa Catarina. The group was founded in 2007 around the HORUS laboratory and has grown through a series of acquisitions of established regional laboratories now marketed under the Widal Pacheco, Endocrimeta, and Conte brands, with subsequent geographic extension into the Porto Alegre metropolitan region via the 2023 acquisitions of Endocrimeta and Conte. The company remains controlled by the Dalbosco family, with Rafael Dalbosco having assumed operational leadership in 2016 and the group opening its capital structure to external shareholders in 2018 to finance continued acquisitions.

The group's core offering is routine and specialized clinical laboratory diagnostics — primarily blood and endocrinology testing — delivered through a distributed collection-point network serving individual patients, referring physicians, and health-plan operators across southern Brazil. The portfolio is differentiated by Endocrimeta's specialized endocrinology testing focus, complementing the routine diagnostics performed under the Widal Pacheco and Conte brands. Quality is anchored by DICQ certification across the network, the Brazilian diagnostic-industry quality standard that supports contracting with health plans and referral sources.

The business model is a regional roll-up of clinical laboratories: revenue is generated per test under fee-for-service pricing paid by patients, private health plans, and referring physicians, with group-level consolidation of procurement, quality, and back-office functions creating scale economics over the acquired standalone laboratories. Grupo WP has stated an ambition to be among Brazil's leading clinical laboratory groups by 2027, supported by its continued acquisition cadence since 2013. The group reports 86 employees across its network and maintains a dedicated careers portal to support integration of recent acquisitions.

Grupo WP: Widal Pacheco - Endocrimeta - Conte firmographics

Firmographics
Name
Grupo WP: Widal Pacheco - Endocrimeta - Conte
Legal name
Grupo WP
Website
https://grupowp.med.br
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
51–100 employees
Short description
Grupo WP is a Brazilian clinical laboratory group operating across 22+ cities in Rio Grande do Sul and Santa Catarina through acquired regional brands (Widal Pacheco, Endocrimeta, Conte), providing routine and specialized endocrinology diagnostic testing to patients and health plans.
Ownership category
akta.pro rank

Grupo WP: Widal Pacheco - Endocrimeta - Conte industry classification

Industry
Product category
Clinical Laboratory Services
NAICS
Medical Laboratories (621511)
SIC
Services-Medical Laboratories (8071)
akta.pro primary industry
Central Laboratory Services (Core Lab Operations) (HLAGAEAA)

Keywords

  • Clinical laboratory services
  • Diagnostic testing services
  • Endocrinology laboratory testing
  • Blood analysis services
  • Medical diagnostic examinations

Where Grupo WP: Widal Pacheco - Endocrimeta - Conte is headquartered

Location

Headquarters

HQ city
Passo Fundo
HQ country
Brazil
HQ region
Latin America

Offices22 records

Markets served

Grupo WP: Widal Pacheco - Endocrimeta - Conte business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Clinical Laboratory Testing Services: Laboratory diagnostic services including clinical analysis, blood tests, specialized examinations, and endocrinology testing (Endocrimeta). Revenue generated through patient examinations and tests, likely on a per-test or service basis.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Grupo WP: Widal Pacheco - Endocrimeta - Conte product offering

Product offering

Core offering

Grupo WP operates a multi-brand network of clinical diagnostic laboratories across southern Brazil, delivering routine and specialized medical examinations to individual patients and referring physicians. Its core services include blood tests, clinical analysis, and specialized endocrinology and metabolic testing through the Endocrimeta brand. The group runs more than 22 physical collection and laboratory units in Rio Grande do Sul and Santa Catarina under the Widal Pacheco, Endocrimeta, and Conte brands.

Product overview

Grupo WP is a unified platform consisting of multiple clinical laboratory brands operating across southern Brazil. The portfolio is structured as a platform-plus-sub-brands architecture, comprising Widal Pacheco (the flagship brand formed from the 2017 fusion of Laboratorio Widal and Laboratorio Pacheco), Endocrimeta, and Conte (both acquired in 2023 to expand into Porto Alegre), along with historical acquisitions including HORUS, Jorgens, and Ambrosio laboratories. The group provides clinical laboratory examination services through 23+ locations across Rio Grande do Sul and Santa Catarina states.

Differentiator

Problem solved

Functional benefit

Products and services

  • Widal Pacheco Clinical laboratory brand formed from the 2017 merger of Laboratorio Widal (Passo Fundo) and Laboratorio Pacheco (Lages), serving Passo Fundo, Lages, and Serra Catarinense regions with general clinical diagnostic testing services.
  • Endocrimeta Clinical laboratory brand acquired in 2023, serving Porto Alegre and metropolitan region with specialization in endocrinology and metabolic testing.
  • Conte Clinical laboratory brand acquired in 2023 as part of Grupo WP's expansion into Porto Alegre and the metropolitan region.

Companies that use Grupo WP: Widal Pacheco - Endocrimeta - Conte

Customer profile

Segments2 records

Ideal customer profiles2 records

Grupo WP: Widal Pacheco - Endocrimeta - Conte technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Grupo WP: Widal Pacheco - Endocrimeta - Conte partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • DICQ - Programa de Certificacao da QualidadecoreOthersDICQ (Programa de Certificação da Qualidade) is a quality certification program for clinical laboratories. The company displays the DICQ certification logo on their website, indicating compliance with quality standards in laboratory operations.

Scale indicators1 record

Recent moves10 records

Expansion highlights5 records

Grupo WP: Widal Pacheco - Endocrimeta - Conte competitors and assessment

Company assessment

Regional players

  • Laboratório São Marcos: Established Brazilian clinical laboratory with long-standing regional presence. Comparable in clinical diagnostic service offerings and patient-referral model, though concentrated in different Brazilian regions.

Direct peers

  • DB Diagnósticos: Brazilian clinical diagnostics network with multiple units and a similar patient-and-physician go-to-market. Comparable as a regionally concentrated Brazilian lab competitor pursuing consolidation.
  • Hermes Pardini: Brazilian clinical analysis laboratory group with strong regional footprint and specialty testing capabilities. Comparable as a mid-sized clinical lab group serving patients and physicians across multiple Brazilian states.
  • Grupo Sabin: Brazilian clinical laboratory and diagnostics group with multi-state presence and a similar multi-brand consolidation strategy. Closely comparable in business model and customer base, though operating at larger national scale.

Broad incumbents

  • Fleury: Major Brazilian medical diagnostics group with broad clinical lab and imaging services. Comparable as a multi-region, multi-brand clinical lab operator targeting similar patient and physician customers.
  • DASA (Diagnósticos da América): Largest clinical diagnostics company in Brazil operating a multi-brand national network of labs and hospitals. Directly comparable as a roll-up acquirer in the same clinical lab market, though materially larger and nationally diversified.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Grupo WP: Widal Pacheco - Endocrimeta - Conte social profiles

Digital presence

Grupo WP: Widal Pacheco - Endocrimeta - Conte compliance and trust

Trust signal

Compliance1 record

Grupo WP: Widal Pacheco - Endocrimeta - Conte financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Grupo WP: Widal Pacheco - Endocrimeta - Conte leadership team

Management profile

Number of profiles

Profiles10 records

Grupo WP: Widal Pacheco - Endocrimeta - Conte subsidiaries and ownership

Company hierarchy

Subsidiaries7 records

Grupo WP: Widal Pacheco - Endocrimeta - Conte funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Grupo WP: Widal Pacheco - Endocrimeta - Conte M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Grupo WP: Widal Pacheco - Endocrimeta - Conte

What does Grupo WP: Widal Pacheco - Endocrimeta - Conte do?

Grupo WP operates a multi-brand network of clinical diagnostic laboratories across southern Brazil, delivering routine and specialized medical examinations to individual patients and referring physicians. Its core services include blood tests, clinical analysis, and specialized endocrinology and metabolic testing through the Endocrimeta brand. The group runs more than 22 physical collection and laboratory units in Rio Grande do Sul and Santa Catarina under the Widal Pacheco, Endocrimeta, and Conte brands.

Is Grupo WP: Widal Pacheco - Endocrimeta - Conte a public or private company?

Grupo WP: Widal Pacheco - Endocrimeta - Conte is a private company. It is classified as family owned and is currently operating.

When was Grupo WP: Widal Pacheco - Endocrimeta - Conte founded?

Grupo WP: Widal Pacheco - Endocrimeta - Conte was founded in 2009. It employs 51 to 100 people.

Where is Grupo WP: Widal Pacheco - Endocrimeta - Conte based?

Grupo WP: Widal Pacheco - Endocrimeta - Conte is headquartered in Passo Fundo, Brazil, in the Latin America region.

How does Grupo WP: Widal Pacheco - Endocrimeta - Conte make money?

One revenue line is on record: clinical Laboratory Testing Services.

Who are Grupo WP: Widal Pacheco - Endocrimeta - Conte's main competitors?

Laboratório São Marcos is listed as a regional player. Direct peers are DB Diagnósticos, Hermes Pardini and Grupo Sabin. Broad incumbents are Fleury and DASA (Diagnósticos da América).

Does Grupo WP: Widal Pacheco - Endocrimeta - Conte have an API?

No public API is recorded for Grupo WP: Widal Pacheco - Endocrimeta - Conte.

What industry is Grupo WP: Widal Pacheco - Endocrimeta - Conte in?

Grupo WP: Widal Pacheco - Endocrimeta - Conte's product category is Clinical Laboratory Services. Its primary akta.pro industry code is HLAGAEAA, Central Laboratory Services (Core Lab Operations). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales